Literature DB >> 17357

The pharmacology of experimental myopathies.

M B Laskowski, W D Dettbarn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 17357     DOI： 10.1146/annurev.pa.17.040177.002131

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN： 0362-1642            Impact factor:   13.820


× No keyword cloud information.
  4 in total

1.  Attenuation of soman-induced lesions of skeletal muscle by acetylcholinesterase reactivating and non-reactivating antidotes.

Authors:  A Dekleva; D Sket; J Sketelj; M Brzin
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

2.  Respiratory failure in acute organophosphorus pesticide self-poisoning.

Authors:  M Eddleston; F Mohamed; J O J Davies; P Eyer; F Worek; M H R Sheriff; N A Buckley
Journal:  QJM       Date:  2006-07-22

3.  Prevention of diisopropylphosphorofluoridate-induced myopathy by botulinum toxin type A blockage of quantal release of acetylcholine.

Authors:  D Sket; W D Dettbarn; M E Clinton; K E Misulis; J Sketelj; D Cucek; M Brzin
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

4.  Agonist-induced myopathy at the neuromuscular junction is mediated by calcium.

Authors:  J P Leonard; M M Salpeter
Journal:  J Cell Biol       Date:  1979-09       Impact factor: 10.539
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.